Navigation Links
Genome BC collaborates with Chile and Norway to sequence salmon genome
Date:12/7/2009

The economically important, environmentally sensitive Atlantic salmon species will have its genome fully sequenced, thanks to an international collaboration involving researchers, funding agencies and industry from Canada, Chile and Norway.

Genome BC is partnering with the Chilean Economic Development Agency, InnovaChile, Norwegian Research Council, Norwegian Fishery and Aquaculture Industry Research Fund to form the International Cooperation to Sequence the Atlantic Salmon Genome (Cooperation).

The Cooperation will invest approximately US$6 million in phase one of a multi-phased project to produce a genome sequence that identifies and maps all of the genes in the Atlantic salmon genome and can act as a reference/guide sequence for the genomes of other salmonids (e.g. Pacific salmon, rainbow trout and more distantly related fish such as smelt and pike.)

With salmonid product exports from Norway, Chile and Canada valued at US$3.4 billion, US$2.3 billion and US$0.6 billion, respectively in 2007, the sequenced genome will be an important public resource that may lead to better management of wild fish stocks, breeding selection for commercially important traits, and elements of food quality, security and traceability.

In addition, the fully annotated salmon genome will provide important clues about the impact of cultured fish escapees on wild populations, conservation of populations at risk, strategies for combating pathogens, as well as allowing for more accurate assessments of the sustainability of aquatic environments.

Dr. Ben Koop sits on the Cooperation's Executive Science Committee. "This project is an international effort to address - in a whole new way - questions that are of economic and social importance to aquaculture, conservation, and the environment," he says.

"The genomic data that we will acquire will be crucial to the development of new methods and products that will assist the world's wild fisheries and aquaculture industries," says Genome BC's Chief Scientific Officer, Dr. Pierre Meulien. "In addition, this research builds on knowledge obtained through earlier fisheries research funded by Genome BC."

Following the release of a Request for Proposals in June 2009, the Cooperation completed a rigorous international scientific peer review process and selected Beckman Coulter Genomics Inc., formerly Agencourt Bioscience and Cogenics, of Beverly, Massachusetts to fulfill the contract for phase one of the project.

Beckman Coulter Genomics, well known for their role in the sequencing of many high profile genomes, will complete phase one of the project, (worth approximately US $6 million,) by early 2011 and release the data as quickly as possible into the public domain.

"This research investment will result in an invaluable resource that can be used by any research group around the world," says Dr. Sigbjrn Lien of the Norwegian University of Life Sciences, and the Cooperation's Executive Science Committee.

Dr. Alejandro Maas of the University of Chile is also a member of the Executive Science Committee. "Through better understanding of this species, and its genome, this timely and strategic research collaboration will enable the growth and management of a global fishery," he says.


'/>"/>

Contact: Sally Greenwood
sgreenwood@genomebc.ca
604-637-4373
Genome BC
Source:Eurekalert

Related biology news :

1. Unravelling new complexity in the genome
2. Conquest of land began in shark genome
3. One species entire genome discovered inside anothers
4. Genome study shines light on genetic link to height
5. First individual genome sequence published
6. Ultraconserved elements in the genome: Are they indispensable?
7. $10 million gift to support cutting-edge epigenome center at USC
8. Fungus genome yielding answers to protect grains, people and animals
9. Which came first, the chicken genome or the egg genome?
10. Researchers expand efforts to explore functional landscape of the human genome
11. Genome update defines landscape of breast and colon cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology: